The effect of topical magnesium sulfate on the progression of effacement, dilatation and duration of labor in nullipar wome
Phase 3
Recruiting
- Conditions
- labor progress.
- Registration Number
- IRCT20120428009576N5
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 98
Inclusion Criteria
Mother age between 18 until 35 years
Being primiparous
Full gestational age 37-42 weeks
Live single fetus with head display and estimated weight 2500-4000 grams
Spontaneous start of the labor process
Body mass index 19.8-30 kg per square meter
Exclusion Criteria
History of infertility
Having risky underlying diseases (heart disease, lung disease, connective tissue and smooth muscle problems, and fetal head incompatibility with the mother's pelvis)
Fetal heart rate problems
Incidence of placental abruption and umbilical cord prolapse
Patient non-cooperation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cervical effacement. Timepoint: At the beginning of the active phase and then every two hours. Method of measurement: Through vaginal examination.;Cervical dilatation. Timepoint: At the beginning of the active phase and then every two hours. Method of measurement: Through vaginal examination.
- Secondary Outcome Measures
Name Time Method Type of delivery. Timepoint: After delivery. Method of measurement: View and record in the file.;Duration of labor. Timepoint: Every two hours. Method of measurement: Per second.;Apgar score. Timepoint: Every two hours. Method of measurement: In terms of score.;Hemoglobin. Timepoint: Six hours after delivery. Method of measurement: Blood test.;Postpartum hemorrhage and rupture of the birth canal. Timepoint: After delivery. Method of measurement: Blood tests and examination.